Mitochondrial DNA Missense Mutations ChrMT: 8981A > G and ChrMT: 6268C > T Identified in a Caucasian Female with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Triggered by the Epstein-Barr Virus. — CFSMEATLAS
Mitochondrial DNA Missense Mutations ChrMT: 8981A > G and ChrMT: 6268C > T Identified in a Caucasian Female with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Triggered by the Epstein-Barr Virus.
Tang-Siegel, Gaoyan G, Maughan, David W, Frownfelter, Milah B et al. · Case reports in genetics · 2024 · DOI
Quick Summary
This study describes one patient with ME/CFS whose symptoms began after a severe viral infection (Epstein-Barr virus, which causes mononucleosis) 24 years ago. Researchers found that her cells had genetic mutations affecting the mitochondria—the 'power plants' that produce energy for our bodies—which may explain her extreme fatigue and difficulty recovering from physical activity. The study also found abnormal mitochondria circulating in her blood, suggesting that energy production problems may be contributing to her ME/CFS symptoms.
Why It Matters
This study provides genetic and cellular evidence supporting the hypothesis that mitochondrial dysfunction is involved in at least some ME/CFS cases, particularly following viral infections. Finding concrete biological markers like defective mitochondrial DNA variants and abnormal circulating mitochondria helps validate ME/CFS as a physical disease rather than a psychological condition, potentially opening new diagnostic and therapeutic avenues.
Observed Findings
Two mitochondrial DNA missense mutations identified: ATP6 (ChrMT: 8981A>G; Q152R) and Cox1 (ChrMT: 6268C>T; A122V)
Abnormal extracellular mitochondria detected in patient's blood via transmission electron microscopy
Disease onset clearly associated with acute Epstein-Barr virus infection (mononucleosis) 24 years prior
Mutations affect the final two enzyme complexes (IV and V) in the mitochondrial respiratory chain responsible for ATP production
Severe, persistent symptoms including postexertional malaise and neurological/cognitive changes over 24-year disease course
Inferred Conclusions
Dysfunctional mitochondria resulting from these specific genetic variants may directly contribute to fatigue and postexertional malaise in this ME/CFS patient
Mitochondrial DNA variants affecting late-stage ATP production enzymes may play a role in ME/CFS pathophysiology
Circulating extracellular mitochondria represent an objective biological marker of mitochondrial dysfunction in this ME/CFS case
Acute viral infections may trigger persistent mitochondrial dysfunction in genetically susceptible individuals
Remaining Questions
How prevalent are these specific mitochondrial mutations in the broader ME/CFS population, and how do they relate to disease severity or symptom patterns?
What This Study Does Not Prove
This single case report does not prove that these specific mitochondrial mutations cause ME/CFS or that they are present in most ME/CFS patients. It cannot establish whether these mutations directly caused the disease, were triggered by the viral infection, or were pre-existing vulnerabilities. The findings cannot be generalized beyond this individual patient without larger population studies.
Did the EBV infection directly cause or unmask pre-existing mitochondrial dysfunction, or do these represent separate risk factors?
What functional consequences do these particular ATP6 and Cox1 variants have on energy production capacity, and can this explain the degree of ATP deficit observed in ME/CFS?
Are circulating extracellular mitochondria a general biomarker of ME/CFS or specific to certain genetic subgroups with mitochondrial variants?